This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Innovations of Jose Miguel Ribalta
Introduction
Jose Miguel Ribalta is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmacology through his innovative work. His research focuses on developing compounds with therapeutic potential, particularly in the area of cardiovascular health.
Latest Patents
Jose Miguel Ribalta holds a patent for a dioxolanic amine with pharmacological activity. This compound, characterized by its structural formula I, exhibits intense vasodilatory, anti-angina, and anti-arrhythmic activity while maintaining low toxicity. The patent also details the method of preparation for this compound, its pharmaceutically acceptable salts, and pharmaceutical compositions that incorporate these compounds. Additionally, Ribalta has developed a new dioxolanic compound, which serves as an intermediate in the preparation of the primary compound.
Career Highlights
Throughout his career, Ribalta has focused on creating innovative solutions to address various pathological conditions. His work has the potential to improve treatment options for patients suffering from cardiovascular diseases. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Jose Miguel Ribalta has collaborated with notable colleagues, including Leonida Bruseghini and Silvano Casadio. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jose Miguel Ribalta's contributions to pharmacology through his innovative patent demonstrate his commitment to advancing medical science. His work not only highlights the importance of research in developing new therapeutic agents but also showcases the potential for innovation in improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile